Farmaceutica REMEDIA S.A. (BVB:RMAH)
Romania · Delayed Price · Currency is RON 0.9000
-0.0140 (-1.53%)
At close: Jan 30, 2026
Farmaceutica REMEDIA Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 753.37 | 743.79 | 593.36 | 535.85 | 477.1 | 441.48 |
Other Revenue | 0 | - | - | - | - | - |
| 753.37 | 743.79 | 593.36 | 535.85 | 477.1 | 441.48 | |
Revenue Growth (YoY) | 5.54% | 25.35% | 10.73% | 12.31% | 8.07% | -1.10% |
Cost of Revenue | 711.17 | 705.14 | 558.54 | 500.19 | 447.83 | 403.69 |
Gross Profit | 42.2 | 38.65 | 34.82 | 35.66 | 29.27 | 37.79 |
Selling, General & Admin | 25.16 | 25.36 | 20.62 | 22.13 | 19.47 | 27.58 |
Amortization of Goodwill & Intangibles | 1.67 | 2.63 | 5.06 | 4.02 | - | 1.1 |
Other Operating Expenses | -2.52 | -1.98 | 2.38 | 3.08 | 0.32 | 6.19 |
Operating Expenses | 24.31 | 26.01 | 28.06 | 29.23 | 21 | 34.87 |
Operating Income | 17.89 | 12.64 | 6.76 | 6.43 | 8.28 | 2.92 |
Interest Expense | -0.05 | -0.1 | -0.12 | -0.16 | -0.11 | -0.17 |
Interest & Investment Income | 1.23 | 1.25 | 0.94 | 0.47 | 0.16 | 0.09 |
Earnings From Equity Investments | 0.18 | -0.11 | -0.28 | - | - | - |
Currency Exchange Gain (Loss) | -0.25 | -0.16 | -0.04 | -0.08 | -0.06 | -0.02 |
Other Non Operating Income (Expenses) | 0.2 | 0.12 | 0.35 | 0.13 | -0.14 | 0.06 |
EBT Excluding Unusual Items | 19.2 | 13.65 | 7.6 | 6.79 | 8.13 | 2.87 |
Gain (Loss) on Sale of Assets | 0.45 | 0.45 | 1.31 | 0.27 | 0.51 | 39.9 |
Pretax Income | 19.64 | 14.09 | 8.91 | 7.06 | 8.63 | 42.77 |
Income Tax Expense | 7.54 | 7.13 | 1.71 | 1.25 | 1.4 | 5 |
Net Income | 12.1 | 6.96 | 7.2 | 5.81 | 7.23 | 37.77 |
Net Income to Common | 12.1 | 6.96 | 7.2 | 5.81 | 7.23 | 37.77 |
Net Income Growth | 358.09% | -3.33% | 23.97% | -19.69% | -80.85% | 1447.31% |
Shares Outstanding (Basic) | 96 | 96 | 96 | 96 | 95 | 106 |
Shares Outstanding (Diluted) | 115 | 96 | 96 | 96 | 95 | 106 |
Shares Change (YoY) | 20.14% | -0.01% | -0.03% | 0.13% | -10.06% | -0.03% |
EPS (Basic) | 0.13 | 0.07 | 0.08 | 0.06 | 0.08 | 0.36 |
EPS (Diluted) | 0.11 | 0.07 | 0.08 | 0.06 | 0.08 | 0.36 |
EPS Growth | 281.31% | -3.32% | 24.01% | -19.79% | -78.71% | 1447.83% |
Free Cash Flow | 28.12 | 17.17 | 21.84 | -2.03 | 2.59 | -13.6 |
Free Cash Flow Per Share | 0.24 | 0.18 | 0.23 | -0.02 | 0.03 | -0.13 |
Dividend Per Share | 0.040 | 0.040 | 0.050 | 0.050 | 0.050 | 0.150 |
Dividend Growth | -20.00% | -20.00% | - | - | -66.67% | - |
Gross Margin | 5.60% | 5.20% | 5.87% | 6.65% | 6.14% | 8.56% |
Operating Margin | 2.37% | 1.70% | 1.14% | 1.20% | 1.74% | 0.66% |
Profit Margin | 1.61% | 0.94% | 1.21% | 1.08% | 1.52% | 8.56% |
Free Cash Flow Margin | 3.73% | 2.31% | 3.68% | -0.38% | 0.54% | -3.08% |
EBITDA | 18.85 | 14.56 | 10.89 | 10.45 | 9.14 | 3.44 |
EBITDA Margin | 2.50% | 1.96% | 1.84% | 1.95% | 1.92% | 0.78% |
D&A For EBITDA | 0.96 | 1.92 | 4.12 | 4.02 | 0.86 | 0.52 |
EBIT | 17.89 | 12.64 | 6.76 | 6.43 | 8.28 | 2.92 |
EBIT Margin | 2.37% | 1.70% | 1.14% | 1.20% | 1.74% | 0.66% |
Effective Tax Rate | 38.39% | 50.60% | 19.16% | 17.69% | 16.22% | 11.68% |
Revenue as Reported | 757.18 | 747.02 | 598.28 | 539.2 | 477.95 | 482.8 |
Advertising Expenses | - | 0.18 | 0.12 | 0.05 | 0.04 | 0.08 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.